TNF is the sole and key promoter of inflammation in several chronic inflammatory and degenerative diseases [14,15,16], including AD [16, 17]
Nonetheless, practitioners must keep educated, use reliable sources, and follow best practices for dosing and patient monitoring, considering different rules and the complexity of peptide compositions
Antioxidant action against carcinogenesis The excess of free radicals in carcinogenic processes induces an oxidative state (OS) that exceeds the body's ability to neutralize them
Future research should further investigate the relationship between these factors and the development of BIPN (Figure 1)
These cost factors significantly influence market pricing dynamics, prompting manufacturers to invest in research and development to identify more cost-effective production alternatives